US Commercial Plans Increase Choice Of Biosimilar And Originator Products; Market Net Prices Decrease
Year: 2024
Type: article
Source: Health Affairs
Institutions: Tufts University, Genentech
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W4402166873
